A novel resveratrol-curcumin hybrid, a19, attenuates high fat diet-induced nonalcoholic fatty liver disease

A novel resveratrol-curcumin hybrid, a19, attenuates high fat diet-induced nonalcoholic fatty liver disease

Both inflammation and fibrosis are essential in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Taking inflammatory cytokines and signaling pathways as vital mediators, the inhibition of inflammation response may be an effective approach for treating NAFLD. a19, a resveratrol-curcumin...

Full description

Bibliographic Details
Main Authors: Beibei Wu, Zhongxiang Xiao, Wenxin Zhang, Hongjin Chen, Hui Liu, Jialing Pan, Xiaohong Cai, Guang Liang, Bin Zhou, Xiaoou Shan, Yali Zhang
Format: Article
Language:English
Published: Elsevier 2019-02-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Non-alcoholic fatty liver disease
Anti-inflammation
Fibrosis
Curcumin
Resveratrol
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332218336394

Internet

http://www.sciencedirect.com/science/article/pii/S0753332218336394

Similar Items